Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT02295696 |
Date of registration:
|
05/11/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
EMMA: Empowerment, Motivation and Medical Adherence
EMMA |
Scientific title:
|
EMMA: Empowerment, Motivation and Medical Adherence |
Date of first enrolment:
|
November 2014 |
Target sample size:
|
270 |
Recruitment status: |
Recruiting |
URL:
|
http://clinicaltrials.gov/show/NCT02295696 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Denmark
| | | | | | | |
Contacts
|
Name:
|
Gitte R Husted, PhD |
Address:
|
|
Telephone:
|
4530753035 |
Email:
|
grhu@steno.dk |
Affiliation:
|
|
|
Name:
|
Gitte R Husted, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Steno Diabetes Center, Denmark |
|
Name:
|
Gitte R Husted, PhD |
Address:
|
|
Telephone:
|
4530753035 |
Email:
|
grhu@steno.dk |
Affiliation:
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Adults Type 2 diabetes = 18 år
- Type 2 diabetes = 1 år
- HbA1c = 64 mmol/mol (= 8%) at the last three measures before randomisation
- Taking medication for Type 2 diabetes • - Speak, read and understands Danish
Exclusion Criteria:
- Participating in other intervention research projects during the trial period
- Being treated by a psychiatrist or psychologist during the period
- Reduced sight or blindness
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Diabetes Mellitus, Type 2
|
Intervention(s)
|
Behavioral: EMMA
|
Primary Outcome(s)
|
HbA1c
[Time Frame: Baseline, 4½ month and 6 months after end of intervention period]
|
Secondary Outcome(s)
|
Self-management
[Time Frame: Baseline, 4½ month and 6 months after end of intervention period]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|